Skip to content
Clinical Trials – home

Carotid artery occlusion Diagnostics

0 / 1 trials open to patients1 country

In short

Carotid artery occlusion is a serious condition that blocks blood flow to the brain, and understanding how it is detected can help you take action before symptoms appear or worsen.

Key points

  • Carotid artery occlusion often develops silently over years, making diagnostic testing crucial for people with risk factors like smoking, high blood pressure, high cholesterol, diabetes, or obesity.
  • Sudden symptoms like facial drooping, slurred speech, vision loss in one eye, or weakness on one side of your body require emergency care immediately, as they may indicate stroke or TIA.
  • Carotid ultrasound is a safe, painless, and non-invasive first-line test that uses sound waves to detect blockages and measure blood flow in your neck arteries.
  • More detailed imaging with CT angiography, MR angiography, or cerebral angiography may be needed to see the exact location and severity of blockages when planning treatment.
  • About 80% of people can function with one carotid artery because brain blood vessels interconnect, but this doesn't eliminate stroke risk from the blocked artery.
  • Clinical trials for carotid disease typically require specific diagnostic tests including duplex ultrasound, advanced imaging, blood tests, and documentation of recent symptoms to determine eligibility.
  • Regular follow-up imaging helps doctors monitor whether blockages are progressing and whether treatments are working effectively to prevent stroke.
  • Your doctor might hear an abnormal "swooshing" sound called a bruit when listening to your neck, which can prompt further diagnostic testing even before you have symptoms.

Introduction: Who Should Undergo Diagnostics

Carotid artery occlusion occurs when one of the large arteries in your neck becomes completely blocked, cutting off or severely limiting blood flow to your brain. These arteries, called the carotid arteries, sit on either side of your neck and are responsible for delivering oxygen-rich blood to your brain, face, and head. When these vessels are blocked by fatty deposits called plaque, the risk of stroke increases dramatically.

Many people with carotid artery problems don't experience any symptoms until something serious happens, such as a stroke or a transient ischemic attack, also known as a TIA or "mini-stroke." Because of this, it's especially important to seek diagnostic testing if you notice sudden warning signs. These include sudden numbness or weakness in your face or limbs, particularly on one side of your body, sudden trouble speaking or understanding speech, sudden vision problems in one or both eyes, sudden dizziness or loss of balance, or a sudden severe headache with no known cause.

If you experience any of these symptoms, even if they only last a short time and then disappear, you should seek emergency care immediately. A TIA may seem harmless because it doesn't cause permanent damage, but it often serves as a serious warning sign that a full stroke could happen soon. Getting evaluated quickly can help doctors identify the blockage and prevent a more devastating event.

Even if you haven't had symptoms, certain factors put you at higher risk for carotid artery disease and make it wise to talk to your doctor about testing. These risk factors include smoking or using tobacco products, having obesity, living a sedentary lifestyle with little physical activity, high blood pressure, high cholesterol, diabetes, and increasing age. The condition becomes more common as people get older, and the combination of multiple risk factors compounds the danger.

Sometimes carotid artery disease is discovered by accident during routine medical examinations. Your doctor might hear an abnormal sound, called a bruit, when listening to your neck with a stethoscope. This swooshing noise is caused by turbulent blood flow through a narrowed artery and can prompt further testing. If your doctor hears this sound, it doesn't automatically mean you have complete blockage, but it does indicate that your arteries need closer examination.

Diagnostic Methods for Identifying Carotid Artery Occlusion

Once a doctor suspects carotid artery disease based on symptoms or risk factors, several diagnostic tests can be used to confirm the presence of blockages and determine how severe they are. The diagnosis usually begins with a medical history review and physical examination. Your doctor will ask about your symptoms, medical conditions, medications, and lifestyle factors. The physical exam often includes listening for a bruit over the carotid arteries in your neck and may also involve tests of your physical and mental abilities, such as strength, memory, and speech, to assess whether the brain has already been affected.

Ultrasound and Doppler Studies

One of the most common and easiest tests for evaluating carotid arteries is carotid ultrasound, also called carotid Doppler ultrasound. This test uses sound waves to create real-time pictures of the arteries and can detect areas where blood flow is restricted. It's a non-invasive procedure, meaning it doesn't require any needles or surgery. During the exam, a technician moves a small device called a transducer over your neck, and the sound waves bounce off the blood vessels to create images on a screen. The Doppler component of the test specifically measures how blood is flowing through your arteries and can identify blockages or narrowing.

This test is often the first step in diagnosing carotid artery disease because it's safe, painless, and provides valuable information about blood flow and pressure in the carotid arteries. If the ultrasound shows significant narrowing or blockage, your doctor may order additional imaging tests to get a more detailed view.

CT and MRI Imaging

Computed tomography, or CT, and magnetic resonance imaging, or MRI, are advanced imaging techniques that can show whether you've had a stroke or if there are other issues affecting your brain and blood vessels. A CT scan uses X-rays to create detailed cross-sectional images of your body, while an MRI uses powerful magnets and radio waves to produce images of soft tissues. Both types of scans can reveal brain damage from previous strokes and help doctors understand the extent of any injury.

When doctors need even more detailed information about blood flow in the carotid arteries, they may use CT angiography or MR angiography. These specialized scans involve injecting a contrast dye into a blood vessel before taking the images. The dye makes the blood vessels stand out clearly in the pictures, allowing doctors to see the exact location and severity of blockages. CT angiography is particularly useful for patients who have pacemakers or metal implants that make MRI unsafe.

Cerebral Angiography

If the less invasive tests cannot provide enough information to determine the cause of symptoms, doctors may recommend cerebral angiography, also known as catheter cerebral angiography or intra-arterial digital subtraction angiography. This is a more invasive test that involves inserting a thin, flexible tube called a catheter into an artery, usually in the groin or wrist. The catheter is carefully guided through the blood vessels to the area of interest in the neck and brain using X-ray imaging.

Once the catheter is in position, a contrast dye is injected through the tube, and X-ray images are captured as the dye flows through the blood vessels. This provides very detailed pictures of the arteries and can help doctors identify the type of plaque clogging the vessels. While this test carries slightly more risk than non-invasive imaging because it requires inserting a catheter, it remains one of the most accurate ways to evaluate complex blockages and plan treatment.

Additional Diagnostic Tools

In some cases, doctors may use other tests to assess the overall health of your cardiovascular system and determine how the blockage is affecting your body. Blood tests can check cholesterol levels, blood sugar, and other markers of heart disease and stroke risk. These lab results help doctors understand the underlying causes of plaque buildup and guide treatment decisions.

Your doctor might also perform an electrocardiogram, or ECG, to evaluate your heart's electrical activity and check for irregular heart rhythms that could contribute to stroke risk. Blood pressure measurements are another important part of diagnosis, since high blood pressure is both a cause and a consequence of carotid artery disease.

Multiple duplex ultrasound examinations over time can help doctors monitor whether blockages are getting worse and whether treatment is working. These follow-up scans are particularly important for patients who have already been diagnosed with carotid artery disease, as they allow healthcare providers to track changes in the arteries and adjust treatment plans accordingly.

Diagnostics for Clinical Trial Qualification

When patients with carotid artery occlusion or severe stenosis are being considered for enrollment in clinical trials, specific diagnostic criteria are typically required to ensure that participants meet the study's eligibility requirements. While the exact tests and measurements can vary depending on the clinical trial's focus, certain diagnostic standards are commonly used across research studies.

Most clinical trials require confirmation of carotid artery disease through duplex ultrasound examination, which can accurately identify and measure the degree of blockage. This imaging technique allows researchers to document the extent of stenosis or whether complete occlusion is present. Trials may specify minimum or maximum percentages of narrowing for inclusion, often categorized as 50 to 69 percent stenosis, 70 to 99 percent stenosis, or complete occlusion.

For symptomatic patients, clinical trials often require documentation of recent neurological events. This typically means patients must have experienced a TIA or minor stroke within a specific timeframe before enrolling in the study, often within three to six months. Researchers need to confirm that symptoms are referable to the affected carotid artery, meaning the symptoms match the area of the brain supplied by that blocked vessel.

Advanced imaging studies such as CT angiography, MR angiography, or cerebral angiography are frequently required to provide detailed anatomical information about the blockage and surrounding blood vessels. These images help researchers understand the characteristics of the plaque, the location of the blockage, and the condition of other blood vessels that supply the brain. Some trials may specifically look for patients with certain types of plaque or particular anatomical features.

Blood tests are another important component of clinical trial screening. Researchers typically measure cholesterol levels, including total cholesterol and low-density lipoprotein (LDL) cholesterol, as well as blood glucose levels to assess for diabetes. These tests help ensure that participants fit the study's criteria and provide baseline measurements for tracking how treatments affect these risk factors over time.

Cardiovascular assessments, including blood pressure measurements and electrocardiograms, are standard requirements for most clinical trials involving carotid artery disease. Some trials may also require echocardiograms to evaluate heart function or to rule out other cardiac sources of stroke risk. Patients with certain heart conditions, such as atrial fibrillation, may be excluded from some studies or specifically recruited for others.

Neurological examinations and cognitive testing may be performed as part of trial screening to document the patient's baseline function. These assessments help researchers measure whether treatments improve or prevent decline in brain function over the course of the study. Tests might include memory assessments, speech evaluation, motor function tests, and quality of life questionnaires.

For trials comparing different treatment approaches, such as surgery versus medical management or different surgical techniques, additional diagnostic procedures may be required. Some studies mandate that all participants undergo cerebral angiography to provide the most detailed anatomical information possible, even if less invasive tests have already confirmed the diagnosis. This ensures that researchers have standardized, high-quality imaging data for all participants.

Medical history documentation is crucial for clinical trial enrollment. Researchers need detailed information about previous strokes or TIAs, other cardiovascular conditions, current medications, and relevant risk factors such as smoking history. This information helps determine whether a patient meets inclusion criteria and doesn't have conditions that would make participation unsafe or interfere with the study's results.

Importantly, clinical trials often exclude patients with certain medical conditions that could complicate treatment or affect outcomes. Common exclusion criteria include severe heart disease, kidney failure, cancer, or other serious illnesses that would significantly limit life expectancy. Patients taking certain medications, particularly those that affect blood clotting, may also be excluded from some studies or required to adjust their medications before enrollment.

Prognosis and Survival Rate

Prognosis

The outlook for patients with carotid artery occlusion depends on several factors, including whether the blockage has caused symptoms, the condition of other blood vessels in the brain, and how well treatment is managed. Interestingly, many people can function with only one carotid artery because the blood vessels in the brain connect with each other, allowing one artery to supply blood to both sides of the brain in about four out of five people. However, this doesn't mean the condition is harmless. Patients with carotid artery occlusion remain at elevated risk for stroke, particularly on the side of the blocked artery.

According to research following patients with internal carotid artery occlusion over time, the majority of patients who are symptomatic at diagnosis had symptoms related to the side of the occluded artery. During follow-up periods, a relatively small percentage of patients experience additional neurological events, with most of these events occurring on the same side as the blockage. The development of additional problems in other blood vessels, particularly blockage or significant narrowing of the external carotid artery on the same side, appears to increase health risks and worsen outcomes.

Risk of progression and complications can be reduced through lifestyle changes and medical management. Patients who stop smoking, control their blood pressure and cholesterol, maintain a healthy weight, and stay physically active have better outcomes than those who don't address these risk factors. Medications to prevent blood clots and manage cholesterol also play an important role in preventing future strokes and improving long-term prognosis.

Survival Rate

Research examining the natural history of carotid artery occlusion has provided important information about survival rates. In one study that followed 80 patients with internal carotid artery occlusion for periods ranging from 1 to 101 months (with an average follow-up of 52 months), 24 percent of patients died during the study period. This represents approximately one in four patients over the course of several years of follow-up.

Analysis of seven-year survival showed that patients who developed disease in the external carotid artery on the same side as the occlusion during follow-up had significantly worse survival compared to those who didn't develop this additional problem. This finding suggests that the progression of vascular disease in multiple vessels is an important predictor of mortality and highlights the importance of ongoing monitoring and aggressive management of risk factors.

It's important to understand that these statistics reflect all causes of death, not just stroke-related deaths. Patients with carotid artery occlusion often have widespread vascular disease affecting other parts of the body, including the heart and legs, which contributes to overall mortality. The condition is associated with atherosclerosis throughout the body, and patients may die from heart attacks or other complications of vascular disease rather than stroke alone.

Survival rates can vary significantly based on individual circumstances. Factors that may improve survival include early diagnosis before symptoms occur, successful management of cardiovascular risk factors, adherence to prescribed medications, and healthy lifestyle choices. Patients who receive appropriate treatment and maintain regular follow-up with their healthcare providers generally have better outcomes than those who don't engage consistently with medical care.

Did you know?

  1. Doctors can sometimes hear a "swooshing" sound called a bruit through a stethoscope when listening to your neck, caused by turbulent blood flow through narrowed carotid arteries, even before you have any symptoms.
  2. About 80% of people can survive with just one functioning carotid artery because the brain's blood vessels are interconnected in a way that allows one artery to supply both sides of the brain.
  3. Carotid artery disease is estimated to affect up to 5% of the general population, yet many people don't know they have it until they experience a stroke or TIA because the condition often develops without any warning signs.

Questions people often ask

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Clinical trials for Carotid artery occlusion

Recruiting trials first

See all 1 trials →
Quick filters

1 clinical trial in this condition

Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Omalizumab
  • Sponsor:Universitair Medisch Centrum Utrecht
See all 1 trials →filters applied: condition = Carotid artery occlusion

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).